Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9573 posts found.

allergan

FDA approves expanded label for Allergan’s Avycaz

June 24, 2016 Medical Communications, Research and Development, Sales and Marketing Allergan, Avycaz, FDA, expanded label

Allergan (NYSE: FDA) has announced that the US Food and Drug Administration (FDA) has approved its supplemental new drug application …
News
cancer

Genmab’s CLL drug gets negative opinion from EMA committee

June 24, 2016 Medical Communications, Research and Development, Sales and Marketing Arzerra, CHMP, CLL, EMA, Genmab, blood cancer

Genmab A/S (Nasdaq Copenhagen: GEN) said its drug Arzerra (ofatumumab) received a negative opinion by the Committee for Medicinal Products …
News
celgene_1_02

Nice rejects Celgene’s drug to treat blood cancer

June 24, 2016 Medical Communications, Research and Development CDF, Celgene, NICE, Vidaza, blood cancer

The National Institute for Health and Care Excellence (Nice) rejected biotech firm Celgene’s (Nasdaq: CELG) Vidaza (azacitidine) to treat a …
News
sanofi_hq__boetie_hall

Sanofi to add future payments onto Medivation offer, according to reports

June 23, 2016 Research and Development, Sales and Marketing Medivation, Sanofi

Sanofi (NYSE: SNY) is considering adding future payments, tied to certain targets, to its proposed $9.3 billion takeover of US …
News

Timely use of Novartis’ Entresto could prevent/delay over 28,000 US deaths a year – study

June 23, 2016 Research and Development, Sales and Marketing Entresto, JAMA Cardiology, Novartis, drug trial, research

A timely switch to Novartis’ (VTX: NOVN) heart failure drug Entresto (sacubitril/valsartan) in patients could prevent or delay more than …
News
humira_abbott_

New Humira data shows improved quality of life in ulcerative colitis patients

June 23, 2016 Research and Development AbbVie, Humira, data, ulcerative colitis

New data on Humira (adalimumab) has been presented at the British Society of Gastroenterology, demonstrating the drug’s efficacy and improvement …
News
gsk_l_rgb

Interview: GSK’s subcutaneous formulation for Benlysta may help cut down hospital visits

June 22, 2016 Research and Development Benlysta, EULAR, Interview, Lupus, NICE, autoimmune diseases, drug trial

UK drugmaker GlaxoSmithKine (LSE: GSK) reported positive results for Benlysta following a late-stage study at the annual European Congress of …
Feature
clinical_trial_3

Wave Life Sciences granted FDA orphan drug designation for Huntington’s disease drug

June 22, 2016 Research and Development FDA, drug, huntington's disease, wave life sciences

Wave Life Sciences (NASDAQ: WVE) has announced that it has received orphan drug designation for the US Food and Drug …
News
entrance_takeda_i020_v1

Takeda begins world’s first norovirus vaccine field trial

June 22, 2016 Research and Development Takeda, Vaccine, norovirus

Takeda Pharmaceuticals (TSE: 4502) has announced that the first patient has received a dosage of their norovirus vaccine candidate, TAK-214, …
News
stocks2

Immunomedics’ chief financial officer resigns, shares fall

June 22, 2016 Research and Development, Sales and Marketing Immunomedics, Shares, cfo, stock market

Shares in Immunomedics (Nasdaq: IMMU) fell as much as 11% after the company said its chief financial officer Peter Pfreundschuh …
News

Nice backs two cancer drugs from Novartis

June 22, 2016 Research and Development, Sales and Marketing AbbVie, Amgen, Humira, NICE, Novartis, Sanofi, lung cancer, skin cancer

The National Institute for Health and Care Excellence (Nice) has backed two drugs form Novartis (VTX: NOVN) for lung cancer …
News
teva_copy

Impax to acquire Teva, Allergan generic drugs for $586 million

June 22, 2016 Research and Development, Sales and Marketing Allergan, Impax, Teva, generics

Impax Laboratories (NASDAQ: IPXL) has announced that it has entered into agreements with Teva and affiliates of Allergan to acquire …
News

Murdo Gordon gets Chief Commercial Officer role at Bristol-Myers Squibb

June 21, 2016 Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing BMS, Bristol-Myers Squibb, chief commercial officer

Bristol-Myers Squibb (NYSE: BMY) has announced the appointment of Munro Gordon as executive vice president and chief commercial officer, effective …
Appointment
amgen_flag

Amgen’s denosumab may help check breast cancer in women with BRCA1 gene – Study

June 21, 2016 Manufacturing and Production, Research and Development Amgen, Prolia, Xgeva, biotech, breast cancer, drug trial, genetics

US biotech firm Amgen’s (Nasdaq: AMGN) Prolia (denosumab) to treat osteoporosis and Xgeva to prevent fractures in cancer patients, may …
News
rd_hands

Auris Medical initiates Phase III trial for sudden deafness treatment

June 21, 2016 Manufacturing and Production, Research and Development auris medical, sudden deafness

Auris Medical (NASDAQ: EARS) has announced that it has initiated enrolment for a new Phase III trial that will evaluate …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025